Breast augmentation is one of the most common cosmetic surgeries in the United States, but it comes with more long-term commitments than many people expect. Implants are not lifetime devices. The chance of complications increases over time, and most people will need at least one additional surgery in their lifetime. Understanding the type of implant, placement options, recovery, costs, and ongoing maintenance will help you make a confident decision.
Saline vs. Silicone Implants
Both saline and silicone implants have an outer shell made of silicone. The difference is what’s inside. Saline implants are filled with sterile salt water, while silicone implants contain a silicone gel. Most people find that silicone feels more similar to natural breast tissue, which is one reason it remains the more popular choice.
There’s an age difference in eligibility: saline implants are available starting at age 18, while silicone implants require you to be at least 22 for cosmetic augmentation. For breast reconstruction after cancer or other medical conditions, silicone implants are available at any age.
One practical distinction matters a lot down the road. If a saline implant ruptures, you’ll know quickly because the breast flattens as the salt water is safely absorbed by your body. Silicone ruptures are harder to detect. The gel tends to stay trapped in the surrounding scar tissue, causing what’s called a silent rupture. You may notice breast pain, thickening, or a change in shape, or you may notice nothing at all. This is why the FDA recommends routine imaging if you have silicone implants.
Where the Implant Is Placed
Your surgeon will discuss two main placement options: under the chest muscle (submuscular) or over the muscle but beneath the breast tissue (subglandular). Each has meaningful trade-offs.
Submuscular placement tends to produce a more natural-looking result. It also leads to more accurate mammograms, since less breast tissue is obscured by the implant, and it carries a lower rate of capsular contracture, a complication where scar tissue tightens around the implant. The downside is more discomfort after surgery and a somewhat longer recovery.
Subglandular (over-the-muscle) placement generally means less post-surgical pain and less implant movement during exercise. However, the appearance can look more artificial, mammogram readings may be less accurate, and capsular contracture rates are higher. This placement may also be preferable for people who want to preserve the option of breastfeeding, since the implant sits below the breast glands.
Incision Options and Scarring
There are three common incision sites, each with different visibility and trade-offs.
- Inframammary (under the breast fold): This is the most widely used approach. It gives the surgeon full visual access for precise placement but leaves a scar along the crease beneath the breast.
- Periareolar (around the nipple): The scar heals to blend with the border of the areola, making it less noticeable. However, this approach can affect nipple sensitivity. One study found temporary sensation changes in about 22% of patients at three months, though that dropped to around 6% by six months.
- Transaxillary (through the armpit): This avoids any scarring on the breast itself and has been associated with minimal impact on nipple sensation. The trade-off is that if a revision is needed later, a second incision on the breast may be required.
Recovery: What the First Six Weeks Look Like
Most people can return to a desk job or other non-physical work within three to five days. You’ll feel sore and tight across the chest, and lifting anything heavier than a few pounds will be off-limits. Sleep on your back during this period, and expect to wear a supportive surgical bra around the clock.
By two weeks, light cardio like walking and gentle stretching or yoga are typically fine. At your six-week post-op visit, your surgeon will evaluate whether you’re ready to gradually return to full activity, including upper-body exercises and heavy lifting. Pushing this timeline can increase the risk of implant shifting or delayed healing.
What It Actually Costs
The average surgeon’s fee for breast augmentation with implants is $4,875, according to the American Society of Plastic Surgeons. Fat grafting augmentation averages $5,719. But the surgeon’s fee is only one piece. You’ll also pay separately for anesthesia, the operating facility, medical tests, prescriptions, and post-surgery garments. The total out-of-pocket cost is often significantly higher than the quoted surgeon’s fee alone. Cosmetic breast augmentation is almost never covered by insurance.
It’s also worth budgeting for the long term. Implants will eventually need to be replaced or removed, and rupture screenings add ongoing costs over the years.
Implants Are Not Lifetime Devices
This is the single most important thing many people overlook. Breast implants will likely need to be replaced at some point. One study found the average time from implant placement to rupture was about six years, though many implants last considerably longer. The FDA updated its screening recommendations in 2020: if you have silicone implants, get an ultrasound or MRI five to six years after placement, then repeat every two to three years. These screenings catch silent ruptures before they cause problems.
Even without a rupture, implants can develop complications over time that require revision surgery. The FDA’s boxed warning on breast implants states plainly that the chance of complications increases the longer you have them, and some of those complications will require additional operations.
Capsular Contracture
Capsular contracture is the most common complication. Your body naturally forms a thin layer of scar tissue around any implant, which is normal. In some cases, that scar tissue tightens and squeezes the implant, causing firmness, discomfort, or visible distortion. Reported rates of clinically significant capsular contracture range from 15% to 45%, and about 92% of these cases develop within the first year after surgery. Newer cohesive gel implants appear to have lower rates, ranging from 0% to roughly 14% in studies.
Capsular contracture is more common with subglandular placement. If it becomes severe, corrective surgery is typically needed to remove or replace the implant and release the tightened tissue.
BIA-ALCL: A Rare but Serious Risk
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a cancer of the immune system linked to breast implants, particularly those with textured surfaces. It is not breast cancer. It develops in the scar tissue and fluid surrounding the implant, usually years after placement.
The risk is very low in absolute terms. Population-based estimates put the incidence at roughly 27 cases per 100 million person-years as of 2022. But that rate has been climbing. It’s substantially higher than the FDA’s earlier estimate of about 3 cases per 100 million person-years from 2001 to 2007. Deaths have occurred, though most cases are treatable when caught early, typically through implant removal and surrounding tissue excision. Textured implants carry the highest risk. If you’re choosing implants, ask your surgeon specifically about smooth versus textured options.
Effects on Mammograms and Breastfeeding
Both saline and silicone implants can obscure mammogram images, reducing the ability to detect breast cancer. This effect is more pronounced with subglandular placement. If your implants are beneath the muscle, interference is significantly less. When you schedule a mammogram, tell the facility you have implants. They’ll use special additional views called implant displacement views to push the implant aside and get a better look at the tissue. Your radiologist may also recommend supplemental ultrasound.
Breastfeeding is possible for many people with implants, though results vary depending on incision location, implant placement, and individual anatomy. Periareolar incisions carry a slightly higher risk of disrupting milk ducts or nerve pathways to the nipple. If future breastfeeding is a priority, discuss this with your surgeon before choosing an approach.
The FDA’s Patient Decision Checklist
Since 2020, the FDA has recommended that all breast implant manufacturers include a patient decision checklist with their products. Your surgeon should provide this before you commit to the procedure. It covers situations where implants should not be used, what makes someone a good candidate, the full range of surgical risks, the importance of your surgeon’s training and experience, the specific risks of BIA-ALCL and systemic symptoms, and a discussion of alternatives to implants. You’re meant to review and complete this checklist before deciding to move forward. If your surgeon doesn’t bring it up, ask for it.
Systemic Symptoms
Some people with breast implants report a cluster of symptoms including fatigue, joint pain, brain fog, and skin rashes, sometimes called breast implant illness. The FDA now formally acknowledges that breast implants have been associated with systemic symptoms, and this is included in the required boxed warning. The exact mechanism isn’t fully understood, and not everyone with implants experiences these issues. For some people, symptoms improve after implant removal. This is worth factoring into your decision, especially if you have a history of autoimmune conditions or unexplained inflammatory symptoms.